The impact of body mass index on heterotopic ossification.


Abstract

Despite similar surgical treatment and prophylactic measures (RT ± indomethacin), the risk of HO appears to significantly increase in patients with higher BMI after DAF. Higher single-fraction doses or multiple fractions and/or combination therapy with nonsteroidal inflammatory drugs may be of greater benefit to these patients.


Full Text


Subjects


Similar articles

Español | English

© Galenicom 1999-2013